While this finding was statistically significant only in the multivariate analysis, this program improved quality of antimicrobial utilization and follow-up. Interestingly, the subgroup analysis in the uninsured population suggests that this intervention

could have a dramatic impact in populations with limited access to care. Other characteristics found to be associated with improved outcome were documented urinary frequency and dysuria; the authors speculate that this may be related to improved EPZ 6438 awareness and aggressive antimicrobial therapy among ED providers responding to these well-defined symptoms of urinary tract infections. In addition, the authors noted a numerical increase in appropriate empiric therapy and a significant increase in the use of nitrofurantoin in the CFU group, corresponding to a change in national and institutional recommendations for cystitis [20]. Despite this, intervention by the multidisciplinary CFU providers was still necessary in 25.5% of cases, and the most common reason for intervention was pathogen non-susceptibility. This is similar to

reports from antimicrobial stewardship programs in other EDs with intervention rates ranging from 15 to 25% [15, 16]. This variance may be due in part to the population Ganetespib mouse that each institution chooses to target. Whilst the authors limited their intervention to urine and blood cultures, others have also included sexually transmitted diseases, skin and skin structure infection, and respiratory tract infections. There are potential limitations to this study that must be considered. The multidisciplinary CFU was only available for culture follow-up Monday–Friday. During weekend shifts, prescribers nearly were instructed

to continue culture follow-up with their same pre-intervention method; in nearly all cases this resulted in delaying intervention until the pharmacist initiated follow-up on Monday. Another limitation was reliance on electronic physician documentation to confirm if the patient was reached for changes in therapy. Calculating the time to appropriate therapy was, therefore, based on the day the physician contacted the patient. Limitations may also exist due to the quasi-experimental design, including potential bias in the assessment of empiric appropriate treatment, the lack of study group randomization, and potential for regression toward the mean in the post-intervention group [21]. A quasi-experimental design was selected for the study because withholding multidisciplinary follow-up from randomly selected patients would be impractical and potentially unethical.

Filling of the pores of the photonic crystal at this tilted position resulted in a shift towards higher wavelength (e.g., at 818 nm). The shift of the central wavelength selleck screening library due to pore-filling is 120 nm for all applied tilting angles, i.e., the gradient of the central wavelength shift due to tilting is the same for the empty and pore-filled photonic crystal as shown in Figure 7.

However, in the case of the pore-filling the reflectance intensity of the central wavelength decreased at the shifted wavelength position as the photonic crystal was optimized for air but not for the pore-filled state. Altogether, the dual tunability provided tuning of the central wavelength in both directions of the measured spectrum approximately 20% around the central wavelength. Figure 7 Measured shift of the central wavelength in case of tilting and pore-filling. System concept A concept of miniaturized MOEMS system with the integration of both tuning principles has been developed. The tilting angle of photonic crystals is limited by the phenomenon of total internal reflection; therefore, angles up to 20° to 40° are required from the system. For a miniaturized actuation system, this tilting range is challenging. Various actuation principles for tilting such as electrostatic, electromagnetic, piezoelectric, and thermoelectric have been evaluated.

Whereas electrostatic actuation with parallel selleck inhibitor charged capacitor plates for rotation is only feasible for small tilting Staurosporine angles, e.g., in milliradian range [15], electrostatic actuation using comb drives and electromagnetic actuator principles have been selected for further study. FEM simulations, analytical calculations, and fabrication process considerations have been performed (to be published separately). Based on the simulation, comb drive-based electrostatic actuation of 20° tilt angle will require around 70 V. On the other hand for the given demands, electromagnetic actuation has the capability for even larger tilt angles especially when using optimized square-shaped torsional beams for suspension of

the porous Si photonic crystal. Additionally, fabrication is less complex. The concept of electromagnetic actuation is shown in Figure 8: an electromagnetically actuated photonic crystal reflector suspended by square-shaped torsional beams can provide tilt angles of up to ±20° at frequencies up to kHz even when using one metal layer only (electroplated 10-μm-thick Cu). Here the maximal possible current density in Cu lines and an outer magnetic field of 2 T were considered. A free-standing silicon plate with integrated porous silicon layers necessary for realization of this concept has been demonstrated before using a SOI process [16]. In the final optical setup, the system is placed in a closed chamber with input and output orifices for gas or liquid and optical input/output fibers.

Chem Educ 7:304–308] Katoh S (1995) The discovery and function of plastocyanin: a personal account. Photosynth Res 43(3):177–189 Katz JJ (1990) Green thoughts Daporinad in a green shade. Photosynth Res 26(3):143–160 Krasnovsky AA (1992) Excited chlorophyll and related problems. Photosynth Res 33:177–193 Krogmann DW (2000) The golden age of biochemical research in photosynthesis. Photosynth Res 63(2):109–121 Menke W (1990)

Retrospective of a botanist. Photosynth Res 25(2):77–82 Myers J (1996) Country boy to scientist. Photosynth Res 50(3):195–208 Myers J (2002) In one ear and out the other. Photosynth Res 73(1–3):21–28 Ochoa S (1980) The pursuit of a hobby. Annu Rev Biochem 49:1–30 Olson JM (1994) Reminiscence about ‘Chloropseudomonas ethylicum’ and the FMO-protein. Photosynth Res 41(1):3–5 Pierson BK (1994) Reflections on Chloroflexux. Photosynth Res 41(1):7–15 Pirson A (1994) Sixty years in algal physiology and photosynthesis. Photosynth Res 40(3):207–221 San Pietro A (2008) Memories: from protein synthesis to photosynthesis. Photosynth Res 96(3):185–199 Shen Y (1994) Dynamic approaches to the mechanism of photosynthesis. Photosynth Res 39(1):1–13 Stanier RY (1980) The journey, not the arrival matters. Annu Rev Microbiol 34:1–48 Sweeney BM (1987) Living in the golden age of biology. Annu Rev Plant Physiol 38:1–9 Tamiya H (1966)

Synchronous cultures of algae. Annu Rev Plant Physiol 17:1–21 Thornber JP (1995) Cabozantinib Thirty years of fun with antenna pigment-proteins and photochemical reaction centers: a tribute to the people who have influenced my career. Photosynth Res 44(1–2):3–22 Tolbert NE (1997) The C2 oxidative photosynthetic cycle. Annu Rev Plant Physiol Plant Mol Biol 48:1–25 Van Niel CB (1967) The education of a microbiologist: some reflections. Annu Rev Microbiol 21:1–30 Vennesland B (1981) Recollections and small confessions. Annu Rev Plant Temsirolimus Physiol 32:1–48 Walker

DA (1997) ‘Tell me where all the past years are’. Photosynth Res 51:1–26 Warburg O (1964) Prefatory chapter. Annu Rev Biochem 33:1–14 Weber G (1990) Whither biophysics. Annu Rev Biophys 19:1–6 Witt HT (1991) Functional mechanism of water splitting photosynthesis. Photosynth Res 29(2):55–77 Zelitch I (2001) Travels in a world of small science. Photosynth Res 67(3):157–176 4 IV Historical papers 2007 Benning C (2007) Questions remaining in sulfolipid biosynthesis: a historical perspective. Photosynth Res 92(2):199–203 Block MA, Douce R, Joyard J, Rolland N (2007) Chloroplast envelop membranes: a dynamic interface between plastids and the cytosol. Photosynth Res 92(2):225–244 Buchanan BB (2007) Thioredoxin: an unexpected meeting place. Photosynth Res 92(2):145–148 Govindjee, Yoo H (2007) The International Society of Photosynthesis Research (ISPR) and its associated international congress on photosynthesis (ICP) a pictoral report. Photosynth Res 91:95–106 Höxtermann E (2007) A comment on Warburg’s early understanding of biocatalysis.

Surf Coat Technol 1997, 94–95:131–136.CrossRef 14. Tamura M, Takahashi M, Ishii J, Suzuki K, Sato M, Shimomura K: Multilayered thermal barrier coating for land-based gas turbines. J Therm Spray Technol 1999, 8:68–72.CrossRef 15. Chrisey DB, Hubler GB (Eds): Pulsed Laser Deposition of Thin Films. New York: Wiley; 1994. 16. Eason R: Pulsed Laser Deposition of Thin Films. Hoboken: Wiley; 2006.CrossRef 17. Balakrishnan G, Kuppusami P, Tripura Sundari S, Thirumurugesan R, Ganesan V, Mohandas E, Sastikumar D: Structural and optical properties of γ-alumina thin films prepared by pulsed laser deposition. Thin Solid Films 2010, 518:3898–3902.CrossRef 18. Balakrishnan G, Kuppusami P, Murugesan S, Ghosh C, Divakar R, Mohandas E, Sastikumar

D: Characterization of Al2O3/ZrO2 nano multilayer thin films prepared by pulsed laser deposition. Mater Chem Phys 2012, 133:299–303.CrossRef CT99021 purchase 19. Aita CR, Hoppe EE, Sorbello RS: Fundamental optical absorption edge of undoped tetragonal zirconium dioxide. Appl Phys Lett 2003, 82:677–679.CrossRef 20. Scanlan CM, Gajdardziska-Josifovska M, Aita CR: Tetragonal zirconia growth by nanolaminates

formation. Appl Phys Lett 1994, 64:3548–3550.CrossRef 21. Zhao Selleckchem FK506 C, Roebben G, Bender H, Young E, Haukka S, Houssa M, Naili M, De Gendt S, Heyns M, Van Der Biest O: In situ crystallisation in ZrO2 thin films during high temperature X-ray diffraction. Microelectronics Reliability 2001, 41:995–998.CrossRef 22. Clemens BM, Kung H, Barnett SA: Structure and strength of multilayers. MRS Bulletin 1999, 24:20–26. 23. Andritschky M, Cunha I, Alpuim P: Thermal stability of zirconia/alumina thin coatings produced by magnetron sputtering. Surf Coat Technol 1997, 94–95:144–148.CrossRef 24. Aita CR: Reactive sputter deposition Aurora Kinase of metal oxide nanolaminates. J Phys Condens Matter 2008, 20:264006.CrossRef 25. Barshilia HC, Deepthi B, Rajam KS: Stabilization of tetragonal and cubic phases of ZrO2 in pulsed sputter deposited Al2O3/ZrO2 and ZrO2/Y2O3 nanolayered thin films. J Appl Phys 2008, 104:113532.CrossRef 26. Schofield MA, Aita CR, Rice PM, Gajdardziska-Josifovska

M: Transmission electron microscopy study of zirconia–alumina nanolaminates grown by reactive sputter deposition. Part I: zirconia nanocrystallite growth morphology. Thin Solid Films 1998, 326:106–116.CrossRef 27. Schofield MA, Aita CR, Rice PM, Gajdardziska-Josifovska M: Transmission electron microscopy study of zirconia–alumina nanolaminates grown by reactive sputter deposition. Part II: zirconia nanocrystallite growth morphology. Thin Solid Films 1998, 326:117–125.CrossRef 28. Garvie RC: Stabilization of the tetragonal structure in zirconia microcrystals. J Phys Chem 1978, 82:218–224.CrossRef 29. Aita CR, Wiggins MD, Whig R, Scanlan CM, Josifovska MG: Thermodynamics of tetragonal zirconia formation in a nanolaminate film. J Appl Phys 1996,79(2):1176–1178.CrossRef 30. Garvie RC: The occurrence of metastable tetragonal zirconia as a crystallite size effect.

JAMA 1967, 201:541–543.CrossRef 53. Oppliger RA, Utter AC, Scott

JR, Dick RW, Klossner D: NCAA rule change improves weight loss among national championship wrestlers. Med Sci Sports Exerc 2006, 38:963–970.PubMedCrossRef 54. ACSM: Position Stand On Weight Loss in Wrestlers. Med Sci Sports Exerc 1976, 8:xi-xiii. Competing interests The authors declare they have no competing find more interests regarding this manuscript. Authors’ contributions All authors have written the first draft of the manuscript, revised it and approved its final version.”
“Background Interest and participation in figure skating has grown consistently over the past 15 years. The US Figure Skating Association USFSA; [1] currently boasts over 176,000 members and 750 member clubs nationwide. While many members participate recreationally, a growing number of athletes strive to join the elite rank of skaters that compete nationally. As the popularity and competition of the sport increases, these figure skaters face growing pressure to complete ever more demanding routines that include advanced jumps and complex technical maneuvers [2–5]. Elite figure skaters must combine strength, endurance and artistry in their on-ice

performances. Skaters’ routines are judged based on their technical merit and presentation with subjective learn more evaluation of their artistic perfection and aesthetic appeal [2, 4]. Small builds, lean figures, and low body weights are valued attributes in female skaters, for both aesthetic and mechanical reasons [3, 4, 6, 7]. Elite skaters must achieve a sleek, graceful bodily appearance while preserving the power, balance and flexibility

a competitive athlete requires [2, 3, 7, Thymidylate synthase 8]. On average, elite adolescent skaters devote 33 hours per week to moderate-to-vigorous physical activity – 27 hours per week to on-ice training and an additional 6 hours per week to off-ice dance and strength training [4]. To promote optimal skating performance, the dietary intakes of figure skaters must meet the energy demands of both intense training and adolescent growth and development [9, 10]. However, intense pressures to conform to the sport’s aesthetic ideal, coupled with traditional societal pressures regarding female weight and body shape, could cause skaters to alter their eating and exercise patterns in unhealthful directions [11–13]. Adolescent skaters face a dual challenge, trying to control body weight for a lean-build sport while meeting the high energy demands of training. Prior studies with elite skaters have shown evidence of energy restriction and inadequate energy intake, along with possible inadequacies in key bone-building nutrients, such as vitamin D, calcium, magnesium and zinc [5, 7, 14–18]. Restrictive eating attitudes and inadequate dietary intake by skaters may lead to a variety of short- and long-term consequences, such as altered athletic performance, fatigue, injuries, amenorrhea and eating disorders [7, 9, 16].

The phase II COIN-B trial randomized patients to receive cetuximab and chemotherapy (Arm D) in an intermittent schedule versus intermittent chemotherapy with continuous cetuximab administration (Arm E). Upon RECIST progression on either arm, the same chemotherapy plus cetuximab was restarted and continued until progression. Continuous cetuximab administration as maintenance was associated with a longer CFI and longer ABT-199 in vitro PFS (5,1 and 13,7 months respectively vs 3,7 and 12 months in the arm D) [43]. The MACRO TTD phase III trial randomized 480

previously untreated mCRC patients to receive 6 cycles of bevacizumab and Xelox followed by Xelox and bevacizumab (arm A) or bevacizumab alone (Arm B). There were not statistically significant differences in PFS and OS between the 2 arms [44]. This study confirmed the efficacy of a maintenance therapy with bevacizumab after a predefined period of chemotherapy induction but did not investigated the role of bevacizumab maintenance in a stop-and-go strategy with a subsequent reintroduction of the same chemotherapy when disease progression Y-27632 supplier occurs. In the ongoing AIO study, maintenance treatment with capecitabine or 5-FU/folinic acid and bevacizumab is

compared with bevacizumab alone or no maintenance treatment in subjects with inoperable and non-progressive metastatic colorectal cancer after first line induction treatment for 24 weeks with a fluoropyrimidine-, oxaliplatin- and bevacizumab-based

chemotherapy. Reinduction treatment will be done in case of progression (Table 3). Table 3 Clinical evidences evaluating different strategies for treatment of mCRC EGFR therapy rechallenge – A multicenter phase II prospective study confirmed the activity of cetuximab rechallenge plus irinotecan-based therapy after an intervening chemotherapy [30] – A phase II prospective study did not show any response to panitumumab administrated after progression on prior cetuximab-based therapy [31] Chemotherapy stop-and go strategy – OPTIMOX 1 study shows that ceasing oxaliplatin after 6 cycles, followed by leucovorin–5-FU alone, achieves RR, PFS, and OS equivalent to that with continuing oxaliplatin Inositol monophosphatase 1 until progression or toxicity [38] – OPTIMOX 2 study shows that continuing treatment with a maintenance chemotherapy led to a longer PFS, compared with pausing treatment [39] – COIN study did not show a non inferiority of chemotherapy free interval versus continuous treatment but treatment holiday significantly reduced cumulative toxic effects, and improved quality of life [41] Biological treatment of chemotherapy-free interval – NORDIC VIII phase III trial showed that cetuximab maintenance do not improve survival data comparing to intermittent treatment [42]. – COIN B phase II trial showed that cetuximab maintenance significantly improved chemotherapy free interval and PFS [43].

The transcriptional profile

of the jamaicamide biosynthetic gene cluster presented here provides insight into the mechanisms by which these pathways are transcribed and potentially regulated. Future advances in classifying promoters and transcription factors find more for cyanobacterial gene clusters will be important to diverse applications in biotechnology, such as combinatorial biosynthesis and the heterologous expression of entire natural product pathways. Additionally, this information should also benefit ongoing efforts attempting to regulate the expression of cyanobacterial toxins with deleterious environmental impacts. Methods Bacterial strains, culture conditions, PCR reactions, and DNA measurements Lyngbya majuscula JHB was originally collected from Hector’s Bay, Jamaica [6] and was maintained in a culture facility at Scripps Institution of Oceanography. Cultures were grown in BG-11 saltwater media at 29°C under a light intensity of approximately 5 μE m-2 s-1 and under 16 h light/8 h dark cycles. E. see more coli TOP-10 and BL-21 (DE3) were grown in Luria-Bertani (LB)

media. E. coli cultures were grown with ampicillin (100 μg ml-1), or kanamycin (50 μg ml-1) when necessary. PCR reactions were conducted using either PCR Master Mix (Promega) or Pfx50 proofreading Taq Polymerase (Invitrogen). DNA concentrations were measured using either Beckman-Coulter DU800 or NanoDrop 1000 (Thermo Reverse transcriptase Scientific) spectrophotometers. Protein concentrations for recombinant JHB proteins were determined using the BCA assay (Pierce). Ladders for DNA (Fermentas and New England Biolabs) and protein (Bio-Rad) were used for size estimations when necessary. RT-PCR using L. majuscula RNA to search for the transcription start site (TSS) and promoter regions in the jamaicamide pathway Cyanobacterial filaments (approximately 2 g wet weight) from a culture of the jamaicamide

producing strain of L. majuscula JHB were harvested and subjected to RNA isolation using TRIzol reagent (Invitrogen) and procedures based on those recommended by the manufacturer with minor modifications. RNA was treated with TURBO DNAse (Ambion) for 2 h at 38°C before use in cDNA reactions. To verify that genomic DNA contamination was not present, in selected cases negative control reactions were run in parallel with cDNA reactions in which reverse transcriptase enzyme was omitted. For the primer extension experiment, first strand cDNA was synthesized from the RNA using the primer upjamA 20-0 R (Sigma Genosys; Additional file 1: Table S1) and the Superscript III Reverse Transcriptase Protocol (Invitrogen) with minor modifications. Second strand reactions were conducted with primers ranging from 500-902 bp upstream in 50 bp increments to determine where RNA transcription upstream of jamA initiated.

We showed that A7 significantly inhibited the growth of non-small cell lung adenocarcinoma in a xenograft mouse model. In this study, human BT474 HER2-amplified estrogen receptor positive breast cancer cells were injected into the mammary fat pad of athymic mice; tumors grew to approximately 200 mm3 prior to infusion with saline or 24 µg/kg/h A7 for 18 days. A marked reduction in tumor volume (5209 ± 419 mm3 to 1656 ± 124 mm3; n = 5, p < 0.05) and weight (3.6 ± 0.2 g to 2.2 ± 0.1 g; n = 5, p < 0.05) was observed in mice administered A7 as compared to saline control animals. Vessel density was decreased approximately 50% Selleck KU-60019 by the heptapeptide,

demonstating that A7 has antiangiogenic properties. Picrosirius red histochemistry showed that interstitial fibrosis (4.91 ± 0.96 percent/field versus 1.22 ± 0.19; n = 17–20, p < 0.0005) and perivascular fibrosis (49.32 ± 3.20 percent/vessel versus 13.35 ± 2.23; n = 20–21, p < 0.0001) were significantly reduced with A7 administration. This decrease in fibrosis was associated with a reduction in collagen I deposition, suggesting that A7 has an antifibrotic effect in breast cancer. Treatment with the heptapeptide

significantly decreased (31% reduction, n = 4, p < 0.05) selleck screening library the in vitro growth of cancer-associated fibroblasts (CAFs) isolated from orthotopic breast tumors

which could lead to a Fossariinae decrease in mitogenic factors and metalloproteinases produced by CAFs. A 2.3-fold increase in the mitogen-activated protein (MAP) kinase phosphatase DUSP1 was also observed, suggesting that the reduction in fibroblast proliferation may be due in part to inhibition of MAP kinase activity. Taken together, these data suggest that A7 may serve as a first-in-class chemotherapeutic agent for breast cancer targeting the tumor microenvironment through a reduction in angiogenesis and a decrease in CAF proliferation. O128 Angiotensin-(1–7) Inhibits VEGF and PlGF to Reduce Tumor Angiogenesis in Triple Negative Breast Cancer in an Orthotopic Mouse Model Patricia E. Gallagher 1 , David R. Soto-Pantoja1, Katherine Cook1, E. Ann Tallant1 1 Hypertension & Vascular Research Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA Triple negative breast tumors are aggressive, highly metastatic cancers that lack estrogen and progesterone receptors and have basal expression of the human epidermal growth factor receptor HER2. Angiotensin-(1–7) [A7], an endogenous heptapeptide hormone that activates the mas receptor, significantly reduced the in vivo proliferation of human triple negative breast tumor growth in an orthotopic model.

The strong red emission peak further suggested that Eu3+ existed in the surface of the SiO2 hollow sphere. The emission spectrum of SiO2 · Eu2O3 HSs consisted of peaks mainly located in the wavelength range from 570 to 700 nm. These peaks corresponded to transitions from the excited state 5 D 0 to the ground state 7 F J (J = 0, 1, 2, 3, 4) of the 4f 6 configuration of Eu3+, as marked in Figure 3. Luminescence originating from

transitions between 4f levels is predominant due to electric dipole or magnetic dipole interactions [40–44]. As can be seen in Figure 3, the strong red emission peak at 612 nm originating from the electric dipole transition 5 D 0 to 7 F 2 was the dominant Vemurafenib band in the measured spectrum. The emission peak at around 590 nm was attributed to the 5 D 0 to 7 F 1 transition. The peaks located at 648 and 695 nm corresponded to 5 D 0 to 7 F 3 and 5 D 0 to

7 F 4 transitions, respectively. Figure 3 The emission spectrum of SiO 2 ∙Eu 2 O 3 HSs. The insert is digital image of SiO2∙Eu2O3 HSs under UV light. Figure 4 shows the Brunauer-Emmett-Teller (BET) N2 adsorption-desorption isotherms and the pore size distribution of the as-prepared SiO2 · Eu2O3 HSs. The BET specific surface area and the total pore Tyrosine Kinase Inhibitor Library nmr volume of the SiO2 · Eu2O3 HSs were measured to be 308.6 m2/g and 0.307 cm3/g, respectively. The pore diameter distribution was relatively wide according to the data of the adsorption branch of the isotherm. The

as-prepared SiO2 · Eu2O3 HSs with a mesoporous structure may possess good performance in drug delivery efficiency, catalytic activity, and so on. Figure 4 N 2 adsorption-desorption isotherm and pore size distribution (insert) of SiO 2 ∙Eu 2 O 3 HSs. Influencing factors of the synthetic process of SiO2 · Re2O3 (Re = Y, Eu, La, Sm, Tb, Pr) hollow structures The experiments showed that the pH value of the solution, reaction temperature and time, and different rare-earth ions and concentrations played an outstanding role in the synthesis of SiO2 · Re2O3 hollow structures, which are discussed in detail as follows. Effect of the pH value of the solution The pH value of the solution was adjusted with dilute nitric acid. The Edoxaban studied pH range was from 7 to 3 under the following reaction conditions: Re3+ = 0.06 mol/L and T = 250°C. Hollow-structure particles could be obtained under the range of 4 ≤ pH < 5.5, and the optimum pH value was 4.5. No hollow structure products appeared when 6 ≤ pH ≤ 8. No HSSs appeared when 2 < pH < 3. Normally, a few HSSs could have emerged in the product at the conditions of 3 < pH < 4.0 or 5 < pH < 6 if the reaction time was more than 10 h. The detailed results are shown in Additional file 1: Table S1 and Figure S3. It is known that SiO2 is an amphoteric oxide which can dissolve into an acidic or basic solvent. The experiments showed that a weak acid solution was in favor of hollow structure formation.

Cas Lek Cesk 1996,135(3):74–78.PubMed 13. Yahya ZA, Bates PC, Millward DJ: Responses to protein deficiency of plasma and tissue insulin-like growth factor-I levels and proteoglycan synthesis rates in rat skeletal muscle and bone. J Endocrinol 1990,127(3):497–503.PubMedCrossRef 14. Takeda S, Kobayashi Y, Park JH, Ezawa I, Omi N: Effect of different levels of dietary protein and physical exercise on bone mineral density and bone strength in growing male rats. J Nutr Sci Vitaminol 2012,58(4):240–246.PubMed 15. Jenkins DJ, Kendall CW, Vidgen E, Augustin LS, Parker T, Faulkner D, Vieth

R, Vandenbroucke AC, Josse RG: Effect of high vegetable protein diets on urinary calcium loss in middle-aged men and women. Eur J Clin Nutr 2003,57(2):376–382.PubMedCrossRef 16. Reeves PG, Nielsen FH, Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Ceritinib ic50 Institute of Nutrition HM781-36B manufacturer ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993,123(11):1939–1951.PubMed 17. Wheeler DL, Graves JE, Miller GL, Vander-Griend RE, Wronski TJ, Powers SK, Park HM: Effects of running in the torisional strength, morphometry, and bone mass of the rat skeleton. Med Sci Sports Exerc 1995,27(4):520–529.PubMed

18. Omi N, Tsukahara N, Ezawa I: Effect of milk on bone metabolism in growing male and female rats. J Home Econ Jpn 2001,52(8):689–698. 19. Ezawa I, Okada R, Nozaki Y, Ogata E: Breaking-properties and ash contents of the femur of growing rat fed a low calcium diet. J Jpn Soc Food Nutr 1979,32(5):329–335. 20. Omi N, Goseki M, Oida S, Sasaki S, Ezawa I: The nutritional evaluation of globin on maintenance of bone metabolism in ovariectomized osteoporotic rats. J Nutr Sci Vitaminol 1994,40(5):443–457.PubMedCrossRef not 21. Guillerminet F, Fabien-Soulé V, Even PC, Tomé D, Benhamou CL, Roux C, Blais A: Hydrolyzed collagen improves bone status and prevents bone loss in ovariectomized C3H/HeN mice. Osteoporos Int 2012,23(7):1909–1919.PubMedCrossRef 22.

Mizoguchi T, Tamura K, Yoshida T, Nagasawa S, Terashima N, Horosawa N, Yagasaki H, Matahira Y, Ito M: Mineral and collagen derived from fish-skin supplementation improves bone metabolism in overiectomized rats part II. J Jpn Dent Mater 2006,25(2):192. 23. Guillerminet F, Beaupied H, Fabien-Soulé V, Tomé D, Benhamou CL, Roux C, Blais A: Hydrolyzed collagen improves bone metabolism and biomechanical parameters in ovariectomized mice: an in vitro and in vivo study. Bone 2010,46(3):827–834.PubMedCrossRef 24. NIH Consensus Development Panel: Osteoporosis prevention, diagnosis, and therapy. JAMA 2001,285(6):785–795.CrossRef 25. Saito M, Fujii K, Marumo K: Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 2006,79(3):160–168.PubMedCrossRef 26.